2011
Personality Disorders and Retention in a Therapeutic Community for Substance Dependence
Samuel DB, LaPaglia DM, Maccarelli LM, Moore BA, Ball SA. Personality Disorders and Retention in a Therapeutic Community for Substance Dependence. American Journal On Addictions 2011, 20: 555-562. PMID: 21999502, PMCID: PMC3856923, DOI: 10.1111/j.1521-0391.2011.00174.x.Peer-Reviewed Original ResearchConceptsAntisocial personality disorderProgram retentionEarly attritionPersonality disorderSubstance use disordersTherapeutic community treatmentPersonality disorder diagnosisSuccessful treatmentTreatment completionRisk individualsTreatment retentionUse disordersCommunity treatmentSurvival analysisPromising interventionSubstance dependenceTC outcomesPremature attritionDisorder diagnosisEarly assessmentTC treatmentDisordersTreatmentTherapeutic communityOutcomes
2009
Substance User Treatment Dropout from Client and Clinician Perspectives: A Pilot Study
Palmer RS, Murphy MK, Piselli A, Ball SA. Substance User Treatment Dropout from Client and Clinician Perspectives: A Pilot Study. Substance Use & Misuse 2009, 44: 1021-1038. PMID: 19938942, PMCID: PMC3678276, DOI: 10.1080/10826080802495237.Peer-Reviewed Original ResearchConceptsClinician's perspectiveTreatment dropoutPilot studyClient-level factorsSample of cliniciansEarly therapeutic allianceAfrican AmericansTreatment retentionTreatment attendanceSubstance user treatmentAlcohol useCliniciansTherapeutic allianceUser treatmentHeavy drugSocial supportCaucasiansTreatmentClient motivationPremature terminationProgram characteristicsPrimary reasonAbstinence
2007
Issues in Designing and Implementing a Spanish‐Language Multi‐Site Clinical Trial
Suarez‐Morales L, Matthews J, Martino S, Ball SA, Rosa C, Farentinos C, Szapocznik J, Carroll KM. Issues in Designing and Implementing a Spanish‐Language Multi‐Site Clinical Trial. American Journal On Addictions 2007, 16: 206-215. PMID: 17612825, PMCID: PMC3628724, DOI: 10.1080/10550490701375707.Peer-Reviewed Original ResearchConceptsClinical trialsMulti-site clinical trialClinical Trials NetworkNIDA Clinical Trials NetworkMotivational enhancement therapySubstance abuse treatmentMulti-site trialClinical staffHealth disparitiesTrials NetworkAbuse treatmentEnhancement therapyTrialsHispanic populationStudy teamAssessment instrumentsDiverse populationsPopulationTherapy
2005
Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation
Ball SA, Carroll KM, Canning-Ball M, Rounsaville BJ. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addictive Behaviors 2005, 31: 320-330. PMID: 15964152, DOI: 10.1016/j.addbeh.2005.05.013.Peer-Reviewed Original ResearchConceptsAbuse treatmentMaladaptive personality functioningSelf-reported assessment dataSubstance abuse treatmentDrug abuse treatmentPersonality functioningClient motivationSubjective reasonsParticipants' symptomsSubstance abuseDropout risk factorsPrevious researchClient's perspectiveMotivationProgram staffOutpatient treatmentEarly attritionAssessment dataDropoutRisk factorsPersonalityFunctioningReengagementSymptomsAbuse
2001
Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement
Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ. Targeting Behavioral Therapies to Enhance Naltrexone Treatment of Opioid Dependence: Efficacy of Contingency Management and Significant Other Involvement. JAMA Psychiatry 2001, 58: 755-761. PMID: 11483141, PMCID: PMC3651594, DOI: 10.1001/archpsyc.58.8.755.Peer-Reviewed Original ResearchConceptsDrug-free urine specimensNaltrexone treatmentFamily counseling sessionsContingency managementOpioid dependenceTreatment retentionUrine specimensBehavioral therapyOpioid-dependent individualsCounseling sessionsDrug use outcomesSubstance abuse outcomesNaltrexone complianceNaltrexone therapyOpioid useAvailable pharmacotherapiesMedication complianceSpecific pharmacotherapySignificant improvementTherapyUse outcomesAbuse outcomesPrincipal outcomePharmacotherapyTreatment